title: EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.
authors.affiliation: Institute of Urology, University of Palermo, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Pavone-Macaluso
authors.forename: F H
authors.initials: FH
authors.lastname: Schröder
authors.forename: H J
authors.initials: HJ
authors.lastname: de Voogt
authors.forename: G
authors.initials: G
authors.lastname: Viggiano
authors.forename: E
authors.initials: E
authors.lastname: Barasolo
authors.forename: B
authors.initials: B
authors.lastname: Lardennois
authors.forename: M
authors.initials: M
authors.lastname: de Pauw
authors.forename: R
authors.initials: R
authors.lastname: Sylvester
authors.forename: P H
authors.initials: PH
authors.lastname: Smith
authors.forename: S
authors.initials: S
authors.lastname: Suciu
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003534:Cyproterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017373:Cyproterone Acetate; D004054:Diethylstilbestrol / Q000627:therapeutic use*; D005060:Europe; D006801:Humans; D008297:Male; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D015337:Multicenter Studies as Topic; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011897:Random Allocation
chemical_list: D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D017373:Cyproterone Acetate; D004054:Diethylstilbestrol; D017258:Medroxyprogesterone Acetate; D003534:Cyproterone; D008525:Medroxyprogesterone